Literature DB >> 16803950

Audit of laboratory mycology services for the management of patients with fungal infections in the northwest of England.

I A Hassan1, P Critten, B Isalska, D W Denning.   

Abstract

BACKGROUND: Fungal infection is increasingly recognised as an important cause of morbidity and mortality, especially in immunocompromised patients. Little information exists on laboratory services available and the methods used by general microbiology laboratories to diagnose these important infections. AIM: To investigate the services microbiology laboratories in northwest England provide towards the diagnosis and management of superficial and deep fungal infections.
METHODS: A questionnaire was sent to laboratories to get a holistic view of the support given to clinicians looking after patients with fungal infections. The aim was not to investigate details of each laboratory's standard operating procedures. The completed questionnaires, which formed the basis of this report, were returned by all 21 laboratories which were recruited. This study was conducted between March 2004 and September 2004.
RESULTS: Services were provided to District General Hospitals and to six tertiary centres, including eight teaching hospitals by 16 laboratories. Their bed capacity was 250-1300 beds. Total specimens (including bacterial and viral) processed annually were 42 000-500,000 whereas fungal ones were 560-5400.
CONCLUSION: In most microbiology laboratories of northwest England, clinicians were aware of the potential of fungal pathogens to cause infections especially in immunocompromised patients. Additional measures such as prolonged incubation of samples were introduced to improve fungal yield from patients at high risk. It is necessary to train and educate laboratory and medical staff about the role of serology and molecular methods in diagnosis and management of patients with fungal infection.

Entities:  

Mesh:

Year:  2006        PMID: 16803950      PMCID: PMC1860420          DOI: 10.1136/jcp.2005.034108

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Economical microscope configuration for direct mycological examination with fluorescence in dermatology.

Authors:  M Monod; S Jaccoud; R Stirnimann; R Anex; F Villa; S Balmer; R Panizzon
Journal:  Dermatology       Date:  2000       Impact factor: 5.366

Review 2.  British Society for Medical Mycology proposed standards of care for patients with invasive fungal infections.

Authors:  David W Denning; Christopher C Kibbler; Rosemary A Barnes
Journal:  Lancet Infect Dis       Date:  2003-04       Impact factor: 25.071

Review 3.  Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis.

Authors:  Monique A S H Mennink-Kersten; J Peter Donnelly; Paul E Verweij
Journal:  Lancet Infect Dis       Date:  2004-06       Impact factor: 25.071

4.  A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis.

Authors:  D Stynen; A Goris; J Sarfati; J P Latgé
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

5.  Performance of cryptococcus antigen latex agglutination kits on serum and cerebrospinal fluid specimens of AIDS patients before and after pronase treatment.

Authors:  J R Hamilton; A Noble; D W Denning; D A Stevens
Journal:  J Clin Microbiol       Date:  1991-02       Impact factor: 5.948

6.  A comparison of calcofluor white, potassium hydroxide, and culture for the laboratory diagnosis of superficial fungal infection.

Authors:  D J Haldane; E Robart
Journal:  Diagn Microbiol Infect Dis       Date:  1990 Jul-Aug       Impact factor: 2.803

7.  Comparison of non-culture-based methods for detection of systemic fungal infections, with an emphasis on invasive Candida infections.

Authors:  P Lewis White; Alice E Archer; Rosemary A Barnes
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

8.  Adverse reactions to voriconazole.

Authors:  Aileen E Boyd; Simon Modi; Susan J Howard; Caroline B Moore; Brian G Keevil; David W Denning
Journal:  Clin Infect Dis       Date:  2004-09-23       Impact factor: 9.079

9.  Potential risk factors for infection with Candida spp. in critically ill patients.

Authors:  D Peres-Bota; H Rodriguez-Villalobos; G Dimopoulos; C Melot; J-L Vincent
Journal:  Clin Microbiol Infect       Date:  2004-06       Impact factor: 8.067

10.  Management and outcome of bloodstream infections due to Candida species in England and Wales.

Authors:  C C Kibbler; S Seaton; R A Barnes; W R Gransden; R E Holliman; E M Johnson; J D Perry; D J Sullivan; J A Wilson
Journal:  J Hosp Infect       Date:  2003-05       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.